{
    "clinical_study": {
        "@rank": "3143", 
        "arm_group": {
            "arm_group_label": "JetTouch injections", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This research study is being done to see how well the JetTouch Needle-Free Endoscopic\n      Injection System is able to deliver a solution safely into the bladder wall. The JetTouch\n      Needle-Free Endoscopic Injection System is a jet injector that allows fluids to be injected\n      into the bladder without using a needle. It is hoped that this method will provide a\n      reliable and consistent method to deliver drugs into the bladder wall."
        }, 
        "brief_title": "JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Subjects", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy individuals (male and female) aged 18-55 without urinary complaints or\n             documented urinary tract dysfunctions.\n\n        Exclusion Criteria:\n\n          -  Unable or unwilling to sign Informed Consent Form or comply with study requirements\n\n          -  Non-English speaking\n\n          -  Currently enrolled in another clinical trial\n\n          -  Undergone treatments given into the bladder in the past 4 weeks\n\n          -  Female subject and has a positive urine pregnancy test at the time of\n             screening/procedure or intends to become pregnant while enrolled\n\n          -  Female subject and is currently breast feeding\n\n          -  Female subject and has given birth in past 6  months\n\n          -  Current or history of chronic urinary tract infections\n\n          -  Current or history of chronic hematuria\n\n          -  Current or history of bladder cancer\n\n          -  History of major surgery in the last 6 months\n\n          -  Current or history of bleeding disorders\n\n          -  Currently taking anticoagulants\n\n          -  Taking aspirin and is unable to discontinue treatment for 2 weeks prior to bladder\n             injection\n\n          -  Taking NSAIDS and is unable to discontinue 48 hours prior to bladder injection\n\n          -  Platelet count, prothrombin time/INR (PT/INR) and partial thromboplastin time (PTT)\n             outside the normal limits of the laboratories established reference ranges\n\n          -  Current or history of any of the following: neurogenic bladder, radiation to pelvic\n             area, inflammation of the bladder wall because of tuberculosis, schistosomiasis,\n             bladder or ureteric calculi\n\n          -  Known hypersensitivity to any of the agents used in the injection (FLEXLINE-Bladder\u00ae\n             Attachment material, lidocaine, saline, Indigo Carmine dye or Ciprofloxacin)\n\n          -  Current or history of any medical condition that in the opinion of the Investigator\n             would make them an unsuitable candidate for this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01862601", 
            "org_study_id": "OT1202"
        }, 
        "intervention": {
            "arm_group_label": "JetTouch injections", 
            "description": "Needle-free injection system believed to provide consistent and reliable delivery of material to the bladder wall.", 
            "intervention_name": "JetTouch Needle-free injection system", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 30, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SE1 9RT"
                    }, 
                    "name": "Guy's Hospital / Quintiles, Ltd."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sheffield", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Sheffield Teaching Hospitals NHS Foundation Trust"
                }
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study to Evaluate the Safety and Performance of the JetTouch Needle-Free Endoscopic Injection System to Deliver Saline Into the Bladder Wall of Healthy Subjects", 
        "overall_official": {
            "affiliation": "Consultant Urological Surgeon, Royal Hallamshire Hospital", 
            "last_name": "Christopher R Chapple, BSc MD DHC FRCS (Urol) FEBU", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Safety of the JetTouch system to deliver saline into the bladder wall.", 
                "safety_issue": "Yes", 
                "time_frame": "within 14 days of the JetTouch procedure"
            }, 
            {
                "measure": "Ability of the JetTouch system to deliver saline into the bladder wall.", 
                "safety_issue": "No", 
                "time_frame": "At the JetTouch procedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01862601"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Physician feedback on the use of the JetTouch system.", 
                "safety_issue": "No", 
                "time_frame": "At the JetTouch Procedure"
            }, 
            {
                "measure": "Physician feedback on perceived subject tolerability of the JetTouch injection procedure.", 
                "safety_issue": "No", 
                "time_frame": "At the JetTouch procedure."
            }, 
            {
                "measure": "Subject feedback question regarding the procedure.", 
                "safety_issue": "No", 
                "time_frame": "At the JetTouch procedure"
            }
        ], 
        "source": "American Medical Systems", 
        "sponsors": {
            "collaborator": {
                "agency": "Quintiles", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "American Medical Systems", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}